Panagora Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.8M Sell
147,569
-557,873
-79% -$64.4M 0.07% 246
2025
Q4
$74.3M Buy
705,442
+567,249
+410% +$53.2M 0.26% 86
2025
Q3
$11.6M Buy
138,193
+90,190
+188% +$7.43M 0.05% 263
2025
Q2
$3.8M Sell
48,003
-770,925
-94% -$61.3M 0.02% 359
2025
Q1
$73.5M Buy
818,928
+522,126
+176% +$48.7M 0.37% 55
2024
Q4
$29.5M Sell
296,802
-976,439
-77% -$101M 0.14% 142
2024
Q3
$145M Buy
1,273,241
+177,951
+16% +$21.1M 0.69% 31
2024
Q2
$136M Buy
1,095,290
+44,550
+4% +$5.74M 0.68% 29
2024
Q1
$139M Sell
1,050,740
-68,602
-6% -$8.46M 0.72% 27
2023
Q4
$122M Buy
1,119,342
+487,428
+77% +$50.6M 0.68% 32
2023
Q3
$65.1M Buy
631,914
+86,144
+16% +$9.28M 0.4% 64
2023
Q2
$63M Buy
545,770
+350,552
+180% +$39.8M 0.37% 70
2023
Q1
$20.8M Sell
195,218
-371,621
-66% -$40.1M 0.13% 167
2022
Q4
$62.9M Sell
566,839
-302,423
-35% -$30.9M 0.41% 57
2022
Q3
$74.9M Sell
869,262
-452,962
-34% -$40.4M 0.52% 38
2022
Q2
$121M Buy
1,322,224
+150,541
+13% +$13.3M 0.79% 16
2022
Q1
$96.1M Buy
1,171,683
+742,473
+173% +$58.5M 0.52% 35
2021
Q4
$32.9M Buy
429,210
+164,536
+62% +$13.1M 0.17% 133
2021
Q3
$19.9M Sell
264,674
-59,801
-18% -$4.55M 0.11% 189
2021
Q2
$25.2M Sell
324,475
-109,427
-25% -$8.14M 0.14% 162
2021
Q1
$31.9M Sell
433,902
-1,007,661
-70% -$74.3M 0.18% 130
2020
Q4
$113M Sell
1,441,563
-166,703
-10% -$12.7M 0.67% 21
2020
Q3
$127M Sell
1,608,266
-137,920
-8% -$10.8M 0.8% 19
2020
Q2
$129M Sell
1,746,186
-155,081
-8% -$11.7M 0.82% 15
2020
Q1
$140M Buy
1,901,267
+216,240
+13% +$17M 0.99% 13
2019
Q4
$146M Buy
1,685,027
+507,605
+43% +$41.7M 0.66% 25
2019
Q3
$94.6M Buy
1,177,422
+88,480
+8% +$7.09M 0.44% 58
2019
Q2
$87.1M Sell
1,088,942
-65,357
-6% -$5M 0.39% 65
2019
Q1
$91.6M Buy
1,154,299
+284,802
+33% +$21.3M 0.41% 55
2018
Q4
$63.4M Sell
869,497
-337,850
-28% -$23.8M 0.3% 84
2018
Q3
$81.7M Buy
1,207,347
+4,572
+0.4% +$291K 0.31% 78
2018
Q2
$69.7M Sell
1,202,775
-562,973
-32% -$31.8M 0.28% 95
2018
Q1
$91.8M Sell
1,765,748
-1,682,691
-49% -$90.9M 0.36% 75
2017
Q4
$185M Sell
3,448,439
-668,488
-16% -$37.1M 0.69% 22
2017
Q3
$252M Sell
4,116,927
-162,443
-4% -$9.85M 1% 14
2017
Q2
$262M Sell
4,279,370
-49,094
-1% -$2.99M 1.05% 11
2017
Q1
$262M Buy
4,328,464
+1,543,485
+55% +$93.6M 1.09% 12
2016
Q4
$156M Buy
2,784,979
+144,034
+5% +$8.43M 0.72% 23
2016
Q3
$157M Buy
2,640,945
+400,194
+18% +$23.4M 0.75% 21
2016
Q2
$123M Buy
2,240,751
+706,048
+46% +$37.6M 0.61% 33
2016
Q1
$77.5M Sell
1,534,703
-618,372
-29% -$30.3M 0.38% 58
2015
Q4
$109M Sell
2,153,075
-79,058
-4% -$3.99M 0.53% 39
2015
Q3
$105M Sell
2,232,133
-311,175
-12% -$16.5M 0.56% 38
2015
Q2
$138M Buy
2,543,308
+41,944
+2% +$2.35M 0.69% 27
2015
Q1
$137M Sell
2,501,364
-112,317
-4% -$6.36M 0.7% 24
2014
Q4
$142M Sell
2,613,681
-314,731
-11% -$17.5M 0.72% 25
2014
Q3
$166M Buy
2,928,412
+160,755
+6% +$9.03M 0.8% 17
2014
Q2
$153M Buy
2,767,657
+195,489
+8% +$10.7M 0.74% 23
2014
Q1
$139M Buy
2,572,168
+97,052
+4% +$5.03M 0.66% 28
2013
Q4
$118M Sell
2,475,116
-129,192
-5% -$5.91M 0.55% 37
2013
Q3
$118M Buy
2,604,308
+45,997
+2% +$2.1M 0.58% 38
2013
Q2
$113M Buy
+2,558,311
New +$114M 0.58% 39

Other funds holding MRK

Panagora Asset Management's MRK Position: Q1 2026 in Review

Panagora Asset Management reduced its Merck (MRK) stake by 79% in Q1 2026, selling an estimated $64.4M and leaving 147,569 shares worth $17.8M. The position accounts for 0.07% of the portfolio, ranked #246.

Panagora Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $262M in Q1 2017. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Panagora Asset Management held 147,569 shares of Merck worth $17.8M as of Q1 2026.
  • Panagora Asset Management sold 557,873 Merck shares in Q1 2026, an estimated $64.4M.
  • Merck made up 0.07% of Panagora Asset Management's portfolio in Q1 2026, its #246 holding.
  • Panagora Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Panagora Asset Management's Merck position peaked at $262M in Q1 2017.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.